Ramipril: Difference between revisions
From Proteopedia
Jump to navigationJump to search
David Canner (talk | contribs) No edit summary |
David Canner (talk | contribs) No edit summary |
||
| Line 6: | Line 6: | ||
* Date of FDA Approval (Patent Expiration): 1991 (2007)<br /> | * Date of FDA Approval (Patent Expiration): 1991 (2007)<br /> | ||
* 2006 Sales: $650 Million | * 2006 Sales: $650 Million | ||
* Why You Should Care: One of the best selling [[Angiotensin-Converting Enzyme]] Inhibitors of all time. | * Why You Should Care: One of the best selling [[Angiotensin-Converting Enzyme]] Inhibitors of all time. Long acting ACE Inhibitor | ||
* The following is a list of Pharmacokinetic Parameters. See: [[Pharmaceutical Drugs]] for more information | * The following is a list of Pharmacokinetic Parameters. See: [[Pharmaceutical Drugs]] for more information | ||
===Mechanism of Action=== | ===Mechanism of Action=== | ||
